Login
$SABS
$2.79 -$0.05 (1.76%) Close

Company Executives

$SABS Management Team

Dr. Eddie Sullivan

President

Director

Age 59
Compensation $1.635M USD
Sex Male

Mr. David Link

Independent Vice Chairman of the Board

Age 70
Compensation $98.56K USD
Sex Male

Ms. Lucy To

Chief Financial Officer

Age 39
Compensation $404.4K USD
Sex Female

Dr. Christoph Bausch

Chief Operating Officer

Age 54
Compensation $1.197M USD
Sex Male

Dr. David Zaccardelli

Chairman of the Board

Age 60
Compensation -
Sex Male

Mr. Samuel Reich

Chief Executive Officer

Director

Age 50
Compensation $2.583M USD
Sex Male

Dr. Alexandra Kropotova

Chief Medical Officer

Age 53
Compensation $1.344M USD
Sex Female
Directors
11
serving now
Independent
9 of 9
stated in the proxy; 2 not stated
Average tenure
4.4 years
from year joined
CEO also chairs the board
No
David Zaccardelli
Director Age On board Independent Committees Other public boards 2025 pay Source
David Zaccardelli
61 2026
0 years
Independent None stated None stated Not stated
Katie Ellias
47 2023
3 years
Independent
Audit Committee Compensation Committee · Chair
None stated $490,255
Andrew Moin
42 2023
3 years
Independent
Nominating and Corporate Governance Committee
None stated Not stated
William Polvino
65 2019
7 years
Independent
Audit Committee
None stated $489,255
Scott Giberson
57 2022
4 years
Independent
Compensation Committee Nominating and Corporate Governance Committee
None stated $488,505
Erick Lucera
58 2023
3 years
Independent
Audit Committee · Chair Compensation Committee
Beyond Air, Bone Biologics Corporation $496,255
Jay S. Skyler
79 2024
2 years
Independent
Nominating and Corporate Governance Committee
None stated $487,255
Samuel J. Reich
51 2020
6 years
Not stated None stated None stated Paid as CEO
Eddie J. Sullivan
60 2014
12 years
Not stated None stated None stated Not stated
Rita Jain
64 2026
0 years
Independent None stated Avalo Therapeutics, AnaptysBio, Inc., Celldex Therapeutics, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support